These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22350594)
1. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients. Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594 [TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia. Cheng S; Teuffel O; Ethier MC; Diorio C; Martino J; Mayo C; Regier D; Wing R; Alibhai SM; Sung L Br J Cancer; 2011 Aug; 105(5):606-11. PubMed ID: 21694729 [TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Teuffel O; Amir E; Alibhai S; Beyene J; Sung L Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048 [TBL] [Abstract][Full Text] [Related]
4. Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice. Haeusler GM; Slavin MA; Bryant PA; Babl FE; Mechinaud F; Thursky KA J Paediatr Child Health; 2018 Jul; 54(7):761-769. PubMed ID: 29655245 [TBL] [Abstract][Full Text] [Related]
5. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV J Pediatr Hematol Oncol; 1999; 21(3):212-8. PubMed ID: 10363854 [TBL] [Abstract][Full Text] [Related]
6. Advances in management of low-risk febrile neutropenia. Teuffel O; Sung L Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219 [TBL] [Abstract][Full Text] [Related]
7. The outpatient management of febrile neutropenia in cancer patients. Freifeld AG; Pizzo PA Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296 [TBL] [Abstract][Full Text] [Related]
8. Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment. Lathia N; Isogai PK; Walker SE; De Angelis C; Cheung MC; Hoch JS; Mittmann N Support Care Cancer; 2013 Jan; 21(1):245-51. PubMed ID: 22684150 [TBL] [Abstract][Full Text] [Related]
9. Willingness to pay to assess patient preferences for therapy in a Canadian setting. Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399 [TBL] [Abstract][Full Text] [Related]
12. Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis. Avilés-Robles MJ; Reyes-López A BMC Health Serv Res; 2024 Aug; 24(1):981. PubMed ID: 39182090 [TBL] [Abstract][Full Text] [Related]
13. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Teuffel O; Ethier MC; Alibhai SMH; Beyene J; Sung L Ann Oncol; 2011 Nov; 22(11):2358-2365. PubMed ID: 21363878 [TBL] [Abstract][Full Text] [Related]
14. [Febrile neutropenia at the emergency department of a cancer hospital]. Debey C; Meert AP; Berghmans T; Thomas JM; Sculier JP Rev Med Brux; 2011; 32(2):74-82. PubMed ID: 21688591 [TBL] [Abstract][Full Text] [Related]
15. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy. Hwang S; Kwon KT; Kim Y; Bae S; Chang HH; Kim SW; Yoo SS; Nam SY; Baek JH Sci Rep; 2021 Sep; 11(1):9048. PubMed ID: 34526516 [TBL] [Abstract][Full Text] [Related]
16. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer. Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377 [TBL] [Abstract][Full Text] [Related]
17. Management of febrile neutropenia in the United Kingdom: time for a national trial? Innes H; Billingham L; Gaunt C; Steven N; Marshall E Br J Cancer; 2005 Dec; 93(12):1324-8. PubMed ID: 16333243 [TBL] [Abstract][Full Text] [Related]
18. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey. Boragina M; Patel H; Reiter S; Dougherty G Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314 [TBL] [Abstract][Full Text] [Related]
19. [Strategies of treatment for febrile neutropenia]. Terui Y Gan To Kagaku Ryoho; 2013 Jun; 40(6):688-92. PubMed ID: 23863644 [TBL] [Abstract][Full Text] [Related]
20. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]